title: Coronary stenting and use of abciximab.
authors.forename: W
authors.initials: W
authors.lastname: Mohl
authors.forename: M
authors.initials: M
authors.lastname: Menges
authors.forename: B
authors.initials: B
authors.lastname: Hennen
authors.forename: H
authors.initials: H
authors.lastname: Schieffer
authors.forename: M
authors.initials: M
authors.lastname: Zeitz
mesh_terms: D000077284:Abciximab; D000800:Angioplasty, Balloon; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab